Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
This study is ongoing, but not recruiting participants.
Study NCT00003262 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: April 18, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
Hodgkin Disease
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Immunoproliferative Disorders
Lentivirus Infections
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
bleomycin sulfate
filgrastim
Stanford V regimen
doxorubicin hydrochloride
epirubicin hydrochloride
etoposide
mechlorethamine hydrochloride
prednisone
vinblastine
vincristine sulfate
Additional drug interventions recognized in this trial
Bleomycin
Doxorubicin
Epirubicin
Mechlorethamine
Vincristine
More general drug interventions related to this trial
Alkylating Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Centro di Riferimento Oncologico - Aviano
Back to top of Main Content
